Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors.
about
Visualizing epigenetics: current advances and advantages in HDAC PET imaging techniquesEpigenetic signaling in psychiatric disorders: stress and depression.Epigenetic mechanisms in schizophrenia.Converging models of schizophrenia--Network alterations of prefrontal cortex underlying cognitive impairments.Prefrontal cortical dysfunction after overexpression of histone deacetylase 1.Therapeutic potential of isoform selective HDAC inhibitors for the treatment of schizophrenia.Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells.Kraepelin revisited: schizophrenia from degeneration to failed regeneration.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms.Spatial genome organization and cognition.The epigenomics of schizophrenia, in the mouse.Risperidone increases the cortical silent period in drug-naive patients with first-episode schizophrenia: A transcranial magnetic stimulation study.Prader-Willi Syndrome: The Disease that Opened up Epigenomic-Based Preemptive MedicineInnovative potential treatment strategies for schizophrenia and biomarkers for Alzheimer's disease.Epigenetic regulation of motivated behaviors by histone deacetylase inhibitors.Oral acetate supplementation attenuates N-methyl D-aspartate receptor hypofunction-induced behavioral phenotypes accompanied by restoration of acetyl-histone homeostasis.The Nuclear Proteome of White and Gray Matter from Schizophrenia Postmortem Brains.Epigenetic therapies - a new direction in clinical medicine.GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia.
P2860
Q26862755-69317F57-FA13-4D69-A49B-FE88F731C0F8Q34426179-71267EF4-C39A-4A38-88A0-C6FA1CD3BF8FQ34426222-14AF6B51-9444-46A0-B74D-DAFA608C6BEEQ36307544-90D8C35D-F4BC-45EA-BE25-A0A71989D84BQ37230971-A74EC314-952E-493E-B5FB-4AED43681F14Q38136307-8F9FA055-FD06-463E-BE45-A256243AB236Q38170728-D5566D4B-108A-4462-B255-07077B98FF0FQ38396447-157692D1-B836-41CD-BE93-93D97C4AE726Q38805367-2AA42C4C-1486-4F19-9D6A-866E8F617E6DQ38973220-769920B7-EEE6-4B31-83C1-ACB51BCB9E09Q39430418-008D0C15-87BB-4E26-A090-6404F8113490Q39487850-1BA1F9BB-FF97-4424-B776-F28DFCC9E561Q42226799-82517BC4-5870-4258-927D-A2AAE53B4099Q43652393-42EED5E6-5471-4C96-ADB3-B1FF535ADC22Q47315020-38919813-AE78-4479-ADD0-D91C85F20E3AQ47595866-BE0A79E4-0E53-4A57-8F07-24BF93F8BEFDQ47844652-A61B355A-D6D9-4D3D-B88D-D13188CCCB46Q51733858-A647A8CA-3175-4458-8595-A3122391F2ECQ53428761-1CDD1966-E922-49ED-91E1-E6F97B9C2D35
P2860
Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epigenetic dysregulation in sc ...... istone deacetylase inhibitors.
@en
type
label
Epigenetic dysregulation in sc ...... istone deacetylase inhibitors.
@en
prefLabel
Epigenetic dysregulation in sc ...... istone deacetylase inhibitors.
@en
P2093
P2860
P1476
Epigenetic dysregulation in sc ...... istone deacetylase inhibitors.
@en
P2093
Amanda Mitchell
Anja Schneider
Schahram Akbarian
Tobias Halene
P2860
P2888
P304
P356
10.1007/S00406-013-0395-2
P577
2013-02-05T00:00:00Z
P5875
P6179
1033861694